None
EN
Pharmac Decision To Increase Access To Type 2 Diabetes Medicines
['Find More', 'Act New Zealand', 'Act New Zeala...', 'New Zealand Labour Party', 'New Zealand National Party', 'New Zealand Government', 'New Zealand Alliance Par...', 'Free Palestine P...', 'New Zealand Taxp...', 'Imogen Brophy -...']
Scoop NZ - Parliament
Pharmac Decision To Increase Access To Type 2 Diabetes MedicinesHon David SeymourAssociate Minister of HealthAssociate Health Minister David Seymour welcomes Pharmac’s decision to widen access to type 2 diabetes medicines based on clinical need.
From 1 September, Pharmac will widen access to empagliflozin, empagliflozin with metformin, liraglutide and dulaglutide for people with type 2 diabetes.
“Pharmac has made the decision to fund these medicines for everybody who needs them, no matter their ethnicity.
Now more people with type 2 diabetes who are at high risk of heart or kidney complications can receive these medicines earlier.
Instead, these medicines will be funded for anyone with type 2 diabetes whose blood sugar levels remain high despite treatment with other funded medicines.